Clinical Application of Denghuo Moxibustion in Treating Post-Stroke Constipation

Objective: To study the clinical application of Denghuo moxibustion in treating post-stroke constipation. Methods: This study included 50 patients with post-stroke constipation admitted from October 2020 to December 2021. They were randomly divided into two groups using the envelope method: 25 patients in the observation group and 25 patients in the control group. The control group received only lactulose, while the observation group received Denghuo moxibustion in addition to lactulose. The efficacy, quality of life (PAC-QOL scale), and laboratory indicators [serum substance P (SP) and vasoactive intestinal peptide (VIP)] were compared between the two groups. Results: The efficacy of the observation group was significantly better than that of the control group (P < 0.05). After treatment, the PAC-QOL scores of both groups decreased significantly, and the improvement in the observation group was more significant (P < 0.05). Changes in laboratory indicators showed that VIP decreased significantly and SP increased significantly in both groups, and the improvement of these two indicators in the observation group was significantly better than that in the control group (P < 0.05). Conclusion: Denghuo moxibustion can enhance the efficacy of lactulose by regulating intestinal neuropeptides and is an effective treatment for post-stroke constipation.